StockData
Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc. (TNYA) stock

TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$0.32−0.01 (-3.24%)

Close on Nov 17, 2026Market cap $72.38MP/E –Yield –

Tenaya Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Tenaya Therapeutics's enterprise value was $5.13M on Nov 11, 2026, against $126.55M a year earlier. Over the last 5 years it ranged from -$190.54M to $301.97M, with a median of $52.70M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.13M-86.0%
2025Dec 31, 2025$36.63M-2.3%
2024Dec 31, 2024$37.49M-60.7%
2023Dec 29, 2023$95.29M-26.4%
2022Apr 29, 2022$129.41M–
2021Dec 31, 2021-$137.48M–

More Tenaya Therapeutics figures

See a number that looks wrong?